Bacillus thuringiensis has been in commercial use as a microbial insecticide for many years. Until recently, it had been assumed that this crystal-forming bacterium was only entomocidal for the agriculturally important Lepidoptera insects. Now, however, a new variety, Bacillus thuringiensis var. israelensis, has been found which is effective against both mosquitoes and black flies. This unexpected observation poses the question how var. israelensis differs from the other B. thruingiensis strains and whether these differences can be further exploited. Information pertaining to these questions should be relevant to an understanding of the molecular basis of host specificity in the microbial insecticides. Since the protein crystal is responsible for the entomocidal activity exhibited by B. thuringiensis, it is the logical starting point for a study on the altered host specificity of var. israelensis. Accordingly, we will compare purified crystals from var. israelensis and selected Lepidoptera-active strains with regard to as many relevant biochemical parameters as possible. Specifically, we will examine: 1/ The influence of crystal morphology (e.g. Amorphous vs. Discrete) on toxicity. 2/ The conditions necessary to solubilize var. israelensis crystals. Solubility is a prerequisite for toxicity. 3/ The presence of chitin barrier in the mosquito larval gut lining. Does var. israelensis have chitinase activity? 4/ The presence and function of interchain disulfide bonds in the var. israelensis crystal. These unusual bonds are the dominant structural features of other B. thuringiensis crystal types. and 5/ The chemical identity of the crystal digestion product which acts as the ultimate mosquito toxin. The purification and characterization of the var. israelensis crystal is underway in our laboratory. Additionally, we have recently demonstrated that the crystal's larval toxicity can be simulated by cyclic peptide ionophores.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI016538-03
Application #
3126697
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Project Start
1983-01-01
Project End
1985-12-31
Budget Start
1985-01-01
Budget End
1985-12-31
Support Year
3
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Nebraska Lincoln
Department
Type
Schools of Arts and Sciences
DUNS #
555456995
City
Lincoln
State
NE
Country
United States
Zip Code
68588
Pfannenstiel, M A; Cray Jr, W C; Couche, G A et al. (1990) Toxicity of protease-resistant domains from the delta-endotoxin of Bacillus thuringiensis subsp. israelensis in Culex quinquefasciatus and Aedes aegypti bioassays. Appl Environ Microbiol 56:162-6
Fedorka-Cray, P J; Cray Jr, W C; Anderson, G A et al. (1988) Bacterial tolerance of 100% dimethyl sulfoxide. Can J Microbiol 34:688-9
Couche, G A; Pfannenstiel, M A; Nickerson, K W (1987) Structural disulfide bonds in the Bacillus thuringiensis subsp. israelensis protein crystal. J Bacteriol 169:3281-8
Muthukumar, G; Nickerson, K W (1987) The glycoprotein toxin of Bacillus thuringiensis subsp. israelensis indicates a lectinlike receptor in the larval mosquito gut. Appl Environ Microbiol 53:2650-5
Pfannenstiel, M A; Muthukumar, G; Couche, G A et al. (1987) Amino sugars in the glycoprotein toxin from Bacillus thuringiensis subsp. israelensis. J Bacteriol 169:796-801
Walther, C J; Couche, G A; Pfannenstiel, M A et al. (1986) Analysis of mosquito larvicidal potential exhibited by vegetative cells of Bacillus thuringiensis subsp. israelensis. Appl Environ Microbiol 52:650-3
Pfannenstiel, M A; Couche, G A; Ross, E J et al. (1986) Immunological relationships among proteins making up the Bacillus thuringiensis subsp. israelensis crystalline toxin. Appl Environ Microbiol 52:644-9
Pfannenstiel, M A; Couche, G A; Muthukumar, G et al. (1985) Stability of the larvicidal activity of Bacillus thuringiensis subsp. israelensis: amino acid modification and denaturants. Appl Environ Microbiol 50:1196-9